Literature DB >> 17272807

Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia.

Alexandra Aicher1, Markus Rentsch, Ken-ichiro Sasaki, Joachim W Ellwart, Fred Fändrich, Reiner Siebert, John P Cooke, Stefanie Dimmeler, Christopher Heeschen.   

Abstract

Circulating progenitor cells home to sites of postnatal neovascularization and differentiate into endothelial cells but questions remain regarding the source of these cells. Indeed, a recent study suggests that nonbone marrow-derived cells may be even more important than bone marrow-derived cells in the setting of transplant arteriosclerosis. Thus, we aimed to thoroughly investigate the contribution of nonbone marrow-derived progenitor cells for neovascularization. We exclusively identified nonbone marrow-derived progenitor cells by combining a parabiosis model with reverse bone marrow transplantation followed by hindlimb ischemia. In this model, nonbone marrow-derived circulating progenitor cells attributed for 74+/-13% of the circulating progenitor cells that incorporated into the ischemic hindlimb. Increasing evidence suggests that organs such as small intestine and liver contain a considerable number of tissue resident progenitor cells and, thus, represent putative sources for nonbone marrow-derived progenitors. To track organ-derived progenitors, we transplanted sex-mismatched small intestine or liver, respectively, into rats followed by induction of hindlimb ischemia. These experiments show that organ-derived progenitor cells are contributing to postnatal vasculogenesis (intestine: 4.7+/-3.7%; liver: 6.3+/-2.2%). Based on the subsequent observation that liver-derived nonhematopoietic c-kit(+)CD45(-) progenitors are mobilized on induction of hindlimb ischemia, we prospectively isolated and intravenously infused these progenitors from murine livers. The isolated cells demonstrated a marked capacity for enhancing neovascularization and restoring blood flow to the ischemic hindlimb (no cells: 26.4+/-4.8% of normal blood flow; c-kit(+)CD45(-) cells: 67.0+/-8.0% of normal flow; P<0.01). In conclusion, we find that nonbone marrow-derived c-kit(+)CD45(-) progenitors contribute to postnatal neovascularization to an extent that is similar to that of bone marrow-derived progenitor cells. Intestine and liver represent a rich source for mobilized tissue-residing progenitor cells.

Entities:  

Mesh:

Year:  2007        PMID: 17272807     DOI: 10.1161/01.RES.0000259562.63718.35

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  72 in total

Review 1.  Resident vascular progenitor cells--diverse origins, phenotype, and function.

Authors:  Peter J Psaltis; Adriana Harbuzariu; Sinny Delacroix; Eric W Holroyd; Robert D Simari
Journal:  J Cardiovasc Transl Res       Date:  2010-11-30       Impact factor: 4.132

2.  The source of neointimal cells in vein grafts: does the origin matter?

Authors:  Heleen Rienstra; Clark J Zeebregts; Jan-Luuk Hillebrands
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

3.  Myocardial Regeneration by Exogenous and Endogenous Progenitor Cells.

Authors:  Annarosa Leri; Toru Hosoda; Marcello Rota; Jan Kajstura; Piero Anversa
Journal:  Drug Discov Today Dis Mech       Date:  2007

Review 4.  Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy.

Authors:  Brown J Martin
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

Review 5.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

Review 6.  An underlying principle for the study of circulating progenitor cells in diabetes and its complications.

Authors:  G P Fadini
Journal:  Diabetologia       Date:  2008-07       Impact factor: 10.122

Review 7.  Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine.

Authors:  Dewi Sukmawati; Rica Tanaka
Journal:  Am J Transl Res       Date:  2015-03-15       Impact factor: 4.060

Review 8.  Endothelial progenitor cells: quo vadis?

Authors:  Matthew R Richardson; Mervin C Yoder
Journal:  J Mol Cell Cardiol       Date:  2010-07-29       Impact factor: 5.000

9.  Mesenchymal stem cells can participate in ischemic neovascularization.

Authors:  Cynthia Hamou; Matthew J Callaghan; Hariharan Thangarajah; Edwin Chang; Eric I Chang; Raymon H Grogan; Josemaria Paterno; Ivan N Vial; Leila Jazayeri; Geoffrey C Gurtner
Journal:  Plast Reconstr Surg       Date:  2009-02       Impact factor: 4.730

10.  Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction.

Authors:  Tashera E Perry; Minjung Song; Daryl J Despres; Soo Mi Kim; Hong San; Zu-Xi Yu; Nalini Raghavachari; Jurgen Schnermann; Richard O Cannon; Donald Orlic
Journal:  Cardiovasc Res       Date:  2009-07-03       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.